Articles

Poll

Podcasts

Slideshows

Videos

Late-breaking data at CHEST 2025 support the novel combination therapy, which may be submitted to the FDA in application for patients with OSA in coming months.

Aroxybutynin and Atomoxetine (AD109) Reduces Obstructive Sleep Apnea Burden in Phase 3 SynAIRgy

CHEST 2025 data suggest OSA is an "effect modifier" on the mortality benefit of GLP-1 receptor agonists in patients co-diagnosed with type 2 diabetes.

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s

Emerging research highlights the critical link between sleep quality and cardiovascular health.

Q3 2025 Recap: Sleep Medicine News and Updates

In this Q&A, Malhotra discusses how tirzepatide impacts obstructive sleep apnea treatment.

Tirzepatide’s Impact on OSA, With Atul Malhotra, MD

New research highlights the benefits of PAP therapy for sleep apnea, showing improvements in blood pressure and cardiometabolic health.

PAP Therapy for Sleep Apnea Linked to Improved Blood Pressure, With Harneet Walia, MD

Weeks discusses how tirzepatide is impacting treatment strategies for obstructive sleep apnea and driving collaboration across specialties.

Tirzepatide’s Role in Obstructive Sleep Apnea Care: Q&A With Brian Weeks, MD

FDA approval of tirzepatide for OSA sparks a surge in referrals as experts highlight weight loss benefits, symptom relief, and patient selection.

Tirzepatide Is A ‘Ray of Hope’ for Patients with OSA: Referral Uptick, Who Benefits

CBT-I improved sleep outcomes and achieved 54% remission in patients with chronic pain, cancer, cardiovascular disease, and other chronic conditions.

CBT-I Effective for Insomnia in Patients with Chronic Diseases

GLP-1 therapies support weight loss, but OSA requires dedicated airway treatment options such as CPAP or neuromuscular stimulation.

Helping Patients Sleep Better: Why the Airway Deserves Its Own Treatment Plan

A recent study shows combined treatment increases total and N3 sleep in just 3 days for patients with comorbid insomnia and depression.


Esketamine Plus Dexmedetomidine Boosts Sleep in Comorbid Insomnia, Depression

Obstructive Sleep Apnea

Insomnia

The HCPLive insomnia page is a comprehensive resource for clinical news and insights on sleeplessness. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for insomnia, and more.

On the HCPLive sleep page, resources on the topics of medical news and expert insight into sleep medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sleep apnea, insomnia, narcolepsy, and more.